US Patent 8012941 Carba-nucleoside analogs for antiviral treatment
Patent 8012941 was granted and assigned to Gilead Sciences on September, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8012941 Carba-nucleoside analogs for antiviral treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
